http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109847064-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109847064-B |
| titleOfInvention | Application of circ _3480 in preparation of nasopharyngeal carcinoma treatment preparation and treatment preparation |
| abstract | The invention belongs to the technical field of tumor molecular biology, and particularly relates to application of circ _3480 in preparation of a nasopharyngeal carcinoma treatment preparation and a treatment preparation. As the siRNA has good silencing effect, after ensuring that the circ _3480 is interfered, MTT experiments are carried out in nasopharyngeal cancer cell lines HONE1, HNE2 and CNE2 which silence the circ _3480, compared with an NC group, the proliferation speed of the cells in the siRNA group is obviously reduced, namely the silencing of the circ _3480 inhibits the proliferation of the nasopharyngeal cancer cells. Namely, the inhibition of circ _3480 can treat nasopharyngeal carcinoma, and has profound clinical significance and important popularization and application prospect. |
| priorityDate | 2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.